Copertina

Enhancing Diagnostic Accuracy in Prostate Oncology: A Multidimensional Perspective on Prostate Specific Antigen Density

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Shengyi Chen, Yuekun Fang, Bin Cheng
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	The Prostate
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Integrating Clinical and Societal Perspectives on Prostate Cancer Research: Addressing Key Limitations and Future Directions
di: Yuekun Fang, et al.
Pubblicazione: (2026)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
di: Elizabeth Robinson, et al.
Pubblicazione: (2025)

Therapeutic Exhaustion After Upfront Androgen Receptor Signaling Inhibitor: A Hidden Determinant of Post‐CRPC Survival
di: Shengyi Chen, et al.
Pubblicazione: (2026)

Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy
di: Yuto Ono, et al.
Pubblicazione: (2025)

A Multimarker Model for Prostate Cancer Risk Assessment: Improving Diagnostic Accuracy Beyond PSA
di: Penglu Yang, et al.
Pubblicazione: (2025)

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide
di: Christian Andrés Martínez Osorio, et al.
Pubblicazione: (2025)

Prostate Volume and PSA‐Density Estimation by Transabdominal Ultrasound: Prospective Evidence of Comparative Accuracy to MRI and Transrectal Ultrasound in Prostate Cancer Early Diagnostics
di: Liza M. Kurucz, et al.
Pubblicazione: (2025)

Multicenter External Validation and Optimization of a Proposed Nomogram for Prostate‐Specific Membrane Antigen PET/CT Accuracy in Biochemical Recurrence
di: Laura Chamorro Castillo, et al.
Pubblicazione: (2025)

Mechanical‐Inflammatory Protection: Explaining Favorable Oncological Outcomes in Large Prostates
di: Yu‐Hsiang Lin, et al.
Pubblicazione: (2025)

Prognostic Impact of Initial Prostate Specific Antigen Half‐Life After Abiraterone Acetate in High‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: Who May Need Triplet Therapy?
di: Kotaro Suzuki, et al.
Pubblicazione: (2026)

Impact of Testosterone Recovery on Oncologic Outcomes in High‐Risk, Localized Prostate Cancer
di: Trevor C. Hunt, et al.
Pubblicazione: (2025)

Serum Levels of Prostate Specific Antigen, Free PSA, [‐2]proPSA, fPSA/tPSA Ratio, Prostate Health Index, and Glycosylation Patterns of Free PSA in Patients With Benign Prostatic Hyperplasia Pharmacotherapy: Limitations and Future Directions
di: Yitong Weng, et al.
Pubblicazione: (2025)

Diagnostic Performance of the Novel Biomarker S2,3PSA Density for Prostate Biopsy Optimization in Prostate Imaging Reporting and Data System 3–5 Lesions
di: Takanori Tokunaga, et al.
Pubblicazione: (2025)

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models
di: Haotian Chen, et al.
Pubblicazione: (2025)

Mortality and Additional Treatment Rates in Pathologically High‐Risk Prostate Cancer With Prostate‐Specific Antigen Persistence at Robot‐Assisted Radical Prostatectomy: Long‐Term Report From Single Tertiary Referral Center
di: Alessandro Bertini, et al.
Pubblicazione: (2025)

Long‐Term Oncological Outcomes of Robot‐Assisted Radical Prostatectomy for Clinically Localized Grade Groups 4 and 5 Prostate Cancers Diagnosed on Prostate Biopsy
di: Victor Sandoval, et al.
Pubblicazione: (2025)

Perioperative Safety and Early Oncologic Outcomes of Salvage Irreversible Electroporation for Radiorecurrent Prostate Cancer
di: Jarrett Noakes, et al.
Pubblicazione: (2026)

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer
di: Marta Victoria Lorenzo‐Sánchez, et al.
Pubblicazione: (2025)

miRNAs Regulating GSTP1 as Potential Diagnostic Biomarkers in Prostate Cancer
di: Shiv Verma, et al.
Pubblicazione: (2025)

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
di: Yifu Shi, et al.
Pubblicazione: (2025)

Towards Precision Oncology: A New Predictive Machine Learning Model for Early Progression to Castration Resistant Prostate Cancer
di: Miguel Ángel Gómez‐Luque, et al.
Pubblicazione: (2025)

Safety and Efficacy of Bipolar Transurethral Vaporization of the Prostate and Bipolar Transurethral Resection of the Prostate in the Management of Large Volume Benign Prostatic Hyperplasia: A Prospective Randomized Study
di: Amr M. Lotfy, et al.
Pubblicazione: (2026)

Evaluating Local Doses for Prostate Cancer Treatment Using Low‐Dose‐Rate Brachytherapy Considering Oncological Control and Toxicity
di: Yasushi Nakai, et al.
Pubblicazione: (2025)

Prostatic Surgery With Preservation of the Supramonticular Tissue Versus Standard Surgery for Benign Prostatic Hyperplasia: A Systematic Review
di: Giuston Mendoza‐Chuctaya, et al.
Pubblicazione: (2025)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
di: Tatsuya Shimomura, et al.
Pubblicazione: (2026)

Enhancing Prostate Cancer Diagnosis: The Combined Value of PHI and mpMRI
di: Y. M. Yáñez‐Castillo, et al.
Pubblicazione: (2025)

Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
di: Cameron J. Britton, et al.
Pubblicazione: (2025)

Safety and Efficacy of Intra‐Prostatic Injection of Betamethasone for Refractory Chronic Nonbacterial Prostatitis: A Prospective Cohort Clinical Study
di: Ahmed Yehia Abdelaziz, et al.
Pubblicazione: (2024)

Discovering the Prostate: Notes on History and Historiography
di: Diederik F. Janssen
Pubblicazione: (2025)

Evidence and Rationale for Prostate Cancer Screening
di: Takeshi Takahashi
Pubblicazione: (2025)

Spatial Characteristics of Intraductal Carcinoma of the Prostate
di: Rodolphe Dupuis, et al.
Pubblicazione: (2025)

Restoration of Mitochondrial Function: A Metabolic Perspective on “Directed Evolution” in Castration‐Resistant Prostate Cancer
di: Po‐Jung Su, et al.
Pubblicazione: (2026)

Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
di: Charly Bâcle, et al.
Pubblicazione: (2025)

Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate‐Risk Prostate Cancer Patients With Node‐Negative PSMA PET
di: Baris Esen, et al.
Pubblicazione: (2025)

USPSTF Recommendation Against PSA Screening vs. Stage and Cancer‐Specific Mortality in Localized Prostate Cancer
di: Fabian Falkenbach, et al.
Pubblicazione: (2025)

Optimizing Prostate Cancer Diagnostic Work‐Up Through Micro‐Ultrasound: Minimizing Unnecessary Procedures and Reducing Overdiagnoses
di: Edoardo Beatrici, et al.
Pubblicazione: (2025)

Mycobacterium Tuberculosis: The Hidden Bacteria in Chronic Prostatitis
di: André Avarese Figueiredo, et al.
Pubblicazione: (2025)

Altered Glycosylation of PSA in Prostate Cancer Tissue
di: Hannu Koistinen, et al.
Pubblicazione: (2025)

Castration Resistance Accelerates Prostate Cancer Kinetics
di: Sheila Jonnatan, et al.
Pubblicazione: (2026)

CHARGE: The “Big Questions” in Prostate Cancer for 2024
di: Andrea K. Miyahira, et al.
Pubblicazione: (2024)